SSRIs Market Expands with Advancements in Antidepressant Therapies and Global Healthcare Access
According to a new report from Intel Market Research, the global Selective Serotonin Reuptake Inhibitors (SSRIs) market was valued at USD 4.69 billion in 2024 and is projected to reach USD 6.05 billion by 2034, growing at a CAGR of 3.8% during the forecast period (2025-2034). This growth is driven by rising mental health awareness, expanded insurance coverage for psychiatric treatments, and the...
0 Comments 0 Shares 8 Views 0 Reviews